4
Changes in Ownership
Cytosorbents Corp Filed Acc 0001104659-20-032715
Chief Operating Officer sold 4,677 shares at $6.00 ($28,062)
- Chief Operating Officer acquired 11,177 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Capponi Vincent · Chief Operating Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-03-10 | Exercise or conversion : show line 1 in the form | +6,500 | $3.45 | $22,425 | 417,649 | D |
| 2020-03-10 | Exercise or conversion : show line 2 in the form | +4,677 | $3.45 | $16,136 | 422,326 | D |
| 2020-03-10 | Sale : show line 3 in the form | −4,677 | $6.00 | $28,062 | 417,649 | D |
| Open-market sales · 4,677 sh · avg $6.00 · $28,062 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-03-10 | Exercise or conversion : show line 4 in the form Stock Option (right to buy) | −6,500 | 14,800 | D |
| 2020-03-10 | Exercise or conversion : show line 5 in the form Stock Option (right to buy) | −4,677 | 10,123 | D |
Loading xslF345X03/tm2011575d4_form4.xml…